We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
In a move that is guaranteed to result in further lawsuits and acrimony, California has signed into law a requirement for pharmaceutical companies to notify and explain any drug pricing increases above a certain threshold.